Veracyte (VCYT) Free Cash Flow Growth (3y) (2015 - 2026)
Veracyte (VCYT) Free Cash Flow Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 10.07% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -7.47% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 53.76% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -16.15% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 14.16% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 23.11% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 40.54% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 5.89% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.16% |
| 10 | Veracyte | 3.62 Bn | 3.32 Bn | 108.55 Mn | 46.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.62% |
| Mar 31, 2026 | 118.95% |
| Dec 31, 2025 | 83.70% |
| Sep 30, 2025 | 99.16% |
| Jun 30, 2025 | 136.63% |
| Mar 31, 2025 | 32.25% |
| Dec 31, 2024 | 38.91% |
| Sep 30, 2024 | 120.01% |
| Jun 30, 2024 | 320.70% |
| Mar 31, 2024 | 35.70% |
| Dec 31, 2023 | 111.85% |
| Sep 30, 2023 | 116.72% |
| Jun 30, 2023 | 51.87% |
| Mar 31, 2023 | 13.99% |
| Dec 31, 2022 | 125.12% |
| Sep 30, 2022 | 70.67% |
| Jun 30, 2022 | 2.65% |
| Mar 31, 2022 | -85.44% |
| Dec 31, 2021 | 86.88% |
| Sep 30, 2021 | -9.49% |